| 000 | 01913 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516112611.0 | ||
| 264 | 0 | _c20130619 | |
| 008 | 201306s 0 0 eng d | ||
| 022 | _a1969-6213 | ||
| 024 | 7 |
_a10.4244/EIJV8I5A92 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKedhi, Elvin | |
| 245 | 0 | 0 |
_aStent thrombosis: insights on outcomes, predictors and impact of dual antiplatelet therapy interruption from the SPIRIT II, SPIRIT III, SPIRIT IV and COMPARE trials. _h[electronic resource] |
| 260 |
_bEuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology _cSep 2012 |
||
| 300 |
_a599-606 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAngioplasty, Balloon, Coronary _xadverse effects |
| 650 | 0 | 4 |
_aCoronary Thrombosis _xprevention & control |
| 650 | 0 | 4 |
_aDrug-Eluting Stents _xadverse effects |
| 650 | 0 | 4 | _aEverolimus |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aSingle-Blind Method |
| 650 | 0 | 4 |
_aSirolimus _xadministration & dosage |
| 700 | 1 | _aStone, Gregg W | |
| 700 | 1 | _aKereiakes, Dean J | |
| 700 | 1 | _aSerruys, Patrick W | |
| 700 | 1 | _aParise, Helen | |
| 700 | 1 | _aFahy, Martin | |
| 700 | 1 | _aSimonton, Charles A | |
| 700 | 1 | _aSudhir, Krishnankutty | |
| 700 | 1 | _aSood, Poornima | |
| 700 | 1 | _aSmits, Pieter C | |
| 773 | 0 |
_tEuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology _gvol. 8 _gno. 5 _gp. 599-606 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4244/EIJV8I5A92 _zAvailable from publisher's website |
| 999 |
_c22120352 _d22120352 |
||